Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(17):1277; doi:10.1093/jnci/djm145
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Screening Interval and Prostate Cancer Incidence

Screening asymptomatic men for prostate cancer has led to an increase in disease incidence. To determine whether the time between screening visits, the screening interval, has an effect on the rate of cancers detected between screening visits, Roobol et al. (p. 1296) analyzed data from two centers involved in the European Randomized Study of Screening for Prostate Cancer. As part of the study, 4,202 men in Gothenburg, Sweden, underwent screening at 2-year intervals, and 13,301 men in Rotterdam, the Netherlands, underwent screening at 4-year intervals. The 10-year cumulative incidence of prostate cancer was 13.14% in Gothenburg and 8.41% in Rotterdam. The cumulative . . . [Full Text of this Article]

Breast Cancer, Hormone Use, and Mammography Screening

Trial of Hypnosis for Surgical Side Effects in Breast Cancer Patients

UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia

OGR1 Acts as a Metastasis Suppressor in Prostate Cancer

H. pylori Genotype, Gastric Cancer, and Precancerous Gastric Lesions

Immune Supression and Squamous Cell Carcinoma of the Eye


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Increased Incidence of Squamous Cell Carcinoma of Eye After Kidney Transplantation
Claire M. Vajdic, Marina T. van Leeuwen, Stephen P. McDonald, Margaret R. E. McCredie, Matthew Law, Jeremy R. Chapman, Angela C. Webster, John M. Kaldor, and Andrew E. Grulich
J Natl Cancer Inst 2007 99: 1340-1342. [Abstract] [Full Text] [PDF]

Interval Cancers in Prostate Cancer Screening: Comparing 2- and 4-Year Screening Intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam
Monique J. Roobol, Anna Grenabo, Fritz H. Schröder, and Jonas Hugosson
J Natl Cancer Inst 2007 99: 1296-1303. [Abstract] [Full Text] [PDF]

A Randomized Clinical Trial of a Brief Hypnosis Intervention to Control Side Effects in Breast Surgery Patients
Guy H. Montgomery, Dana H. Bovbjerg, Julie B. Schnur, Daniel David, Alisan Goldfarb, Christina R. Weltz, Clyde Schechter, Joshua Graff-Zivin, Kristin Tatrow, Donald D. Price, and Jeffrey H. Silverstein
J Natl Cancer Inst 2007 99: 1304-1312. [Abstract] [Full Text] [PDF]

Ovarian Cancer G Protein–Coupled Receptor 1, a New Metastasis Suppressor Gene in Prostate Cancer
Lisam Shanjukumar Singh, Michael Berk, Rhonda Oates, Zhenwen Zhao, Haiyan Tan, Ying Jiang, Aimin Zhou, Kashif Kirmani, Rosemary Steinmetz, Daniel Lindner, and Yan Xu
J Natl Cancer Inst 2007 99: 1313-1327. [Abstract] [Full Text] [PDF]

Declines in Invasive Breast Cancer and Use of Postmenopausal Hormone Therapy in a Screening Mammography Population
Karla Kerlikowske, Diana L. Miglioretti, Diana S. M. Buist, Rod Walker, and Patricia A. Carney
J Natl Cancer Inst 2007 99: 1335-1339. [Abstract] [Full Text] [PDF]

UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters
Janelle M. Hoskins, Richard M. Goldberg, Pingping Qu, Joseph G. Ibrahim, and Howard L. McLeod
J Natl Cancer Inst 2007 99: 1290-1295. [Abstract] [Full Text] [PDF]

Helicobacter pylori Cytotoxin-Associated Genotype and Gastric Precancerous Lesions
Martyn Plummer, Leen-Jan van Doorn, Silvia Franceschi, Bernhard Kleter, Federico Canzian, Jorge Vivas, Gladys Lopez, Didier Colin, Nubia Muñoz, and Ikuko Kato
J Natl Cancer Inst 2007 99: 1328-1334. [Abstract] [Full Text] [PDF]

Is a Screening Interval of Every 4 Years for Prostate Cancer Acceptable?
E. David Crawford
J Natl Cancer Inst 2007 99: 1279-1280. [Extract] [Full Text] [PDF]

The Mind Prepared: Hypnosis in Surgery
David Spiegel
J Natl Cancer Inst 2007 99: 1280-1281. [Extract] [Full Text] [PDF]